Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Prestige Consumer Healthcare's EV/EBITDA was 12.6× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 7.7× to 560.2×, with a median of 12.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.6× | +4.4 |
| 2025 | Dec 31, 2025 | 8.2× | −5.6 |
| 2024 | Dec 31, 2024 | 13.8× | −380.1 |
| 2023 | Dec 29, 2023 | 393.9× | +381.3 |
| 2022 | Dec 30, 2022 | 12.6× | −0.9 |
| 2021 | Dec 31, 2021 | 13.5× | +3.6 |
| 2020 | Dec 31, 2020 | 9.9× | −30.5 |
| 2019 | Dec 31, 2019 | 40.4× | +25.6 |
| 2018 | Dec 31, 2018 | 14.7× | +0.3 |
| 2017 | Dec 29, 2017 | 14.4× | −3.4 |
| 2016 | Dec 30, 2016 | 17.9× | +2.6 |
| 2015 | Dec 31, 2015 | 15.3× | −3.2 |
| 2014 | Dec 31, 2014 | 18.5× | +5.4 |
| 2013 | Dec 31, 2013 | 13.2× | −0.3 |
| 2012 | Dec 31, 2012 | 13.5× | +3.3 |
| 2011 | Dec 30, 2011 | 10.3× | +4.0 |
| 2010 | Dec 31, 2010 | 6.2× | – |
See a number that looks wrong?